 | • レポートコード：D0GIR-02745 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、脳腫瘍治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。脳腫瘍治療の種類別市場規模（外科、放射線療法、化学療法、免疫療法、その他）、用途別市場規模（病院・クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Genetech (U.S.)、Merck (U.S.)、Astra Zeneca (India)、Bristol Mayers Squibb (U.S.)、Antisenese Pharma (Mongolia)、Hoffman-La Roche (Switzerland)、Mankind Pharma (India)、Novartis (Switzerland)、Pfizer (U.S.)、Mcleod’s Pharmaceuticals (India)、Dr. Reddy’s Laboratories (India) ・地域別グローバル市場分析 2015年-2020年 ・脳腫瘍治療の北米市場（アメリカ、カナダ、メキシコ） ・脳腫瘍治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・脳腫瘍治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・脳腫瘍治療の南米市場（ブラジル、アルゼンチン） ・脳腫瘍治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：外科、放射線療法、化学療法、免疫療法、その他 ・用途別分析：病院・クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Brain Tumor Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Brain Tumor Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Brain Tumor Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Brain Tumor Treatment market has been segmented into:
Surgery
Radiation Therapy
Chemotherapy
Immunotherapy
Others
By Application, Brain Tumor Treatment has been segmented into:
Hospitals and Clinics
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Brain Tumor Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Brain Tumor Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Brain Tumor Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Brain Tumor Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Brain Tumor Treatment Market Share Analysis
Brain Tumor Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Brain Tumor Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Brain Tumor Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Brain Tumor Treatment are:
Genetech (U.S.)
Merck (U.S.)
Astra Zeneca (India)
Bristol Mayers Squibb (U.S.)
Antisenese Pharma (Mongolia)
Hoffman-La Roche (Switzerland)
Mankind Pharma (India)
Novartis (Switzerland)
Pfizer (U.S.)
Mcleod’s Pharmaceuticals (India)
Dr. Reddy’s Laboratories (India)
Table of Contents
1 Brain Tumor Treatment Market Overview
1.1 Product Overview and Scope of Brain Tumor Treatment
1.2 Classification of Brain Tumor Treatment by Type
1.2.1 Global Brain Tumor Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Brain Tumor Treatment Revenue Market Share by Type in 2019
1.2.3 Surgery
1.2.4 Radiation Therapy
1.2.5 Chemotherapy
1.2.6 Immunotherapy
1.2.7 Others
1.3 Global Brain Tumor Treatment Market by Application
1.3.1 Overview: Global Brain Tumor Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals and Clinics
1.3.3 Others
1.4 Global Brain Tumor Treatment Market by Regions
1.4.1 Global Brain Tumor Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Brain Tumor Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Brain Tumor Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Brain Tumor Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Brain Tumor Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Brain Tumor Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Brain Tumor Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Genetech (U.S.)
2.1.1 Genetech (U.S.) Details
2.1.2 Genetech (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Genetech (U.S.) SWOT Analysis
2.1.4 Genetech (U.S.) Product and Services
2.1.5 Genetech (U.S.) Brain Tumor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck (U.S.)
2.2.1 Merck (U.S.) Details
2.2.2 Merck (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merck (U.S.) SWOT Analysis
2.2.4 Merck (U.S.) Product and Services
2.2.5 Merck (U.S.) Brain Tumor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Astra Zeneca (India)
2.3.1 Astra Zeneca (India) Details
2.3.2 Astra Zeneca (India) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Astra Zeneca (India) SWOT Analysis
2.3.4 Astra Zeneca (India) Product and Services
2.3.5 Astra Zeneca (India) Brain Tumor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bristol Mayers Squibb (U.S.)
2.4.1 Bristol Mayers Squibb (U.S.) Details
2.4.2 Bristol Mayers Squibb (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bristol Mayers Squibb (U.S.) SWOT Analysis
2.4.4 Bristol Mayers Squibb (U.S.) Product and Services
2.4.5 Bristol Mayers Squibb (U.S.) Brain Tumor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Antisenese Pharma (Mongolia)
2.5.1 Antisenese Pharma (Mongolia) Details
2.5.2 Antisenese Pharma (Mongolia) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Antisenese Pharma (Mongolia) SWOT Analysis
2.5.4 Antisenese Pharma (Mongolia) Product and Services
2.5.5 Antisenese Pharma (Mongolia) Brain Tumor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Hoffman-La Roche (Switzerland)
2.6.1 Hoffman-La Roche (Switzerland) Details
2.6.2 Hoffman-La Roche (Switzerland) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Hoffman-La Roche (Switzerland) SWOT Analysis
2.6.4 Hoffman-La Roche (Switzerland) Product and Services
2.6.5 Hoffman-La Roche (Switzerland) Brain Tumor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Mankind Pharma (India)
2.7.1 Mankind Pharma (India) Details
2.7.2 Mankind Pharma (India) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Mankind Pharma (India) SWOT Analysis
2.7.4 Mankind Pharma (India) Product and Services
2.7.5 Mankind Pharma (India) Brain Tumor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis (Switzerland)
2.8.1 Novartis (Switzerland) Details
2.8.2 Novartis (Switzerland) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis (Switzerland) SWOT Analysis
2.8.4 Novartis (Switzerland) Product and Services
2.8.5 Novartis (Switzerland) Brain Tumor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfizer (U.S.)
2.9.1 Pfizer (U.S.) Details
2.9.2 Pfizer (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Pfizer (U.S.) SWOT Analysis
2.9.4 Pfizer (U.S.) Product and Services
2.9.5 Pfizer (U.S.) Brain Tumor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Mcleod’s Pharmaceuticals (India)
2.10.1 Mcleod’s Pharmaceuticals (India) Details
2.10.2 Mcleod’s Pharmaceuticals (India) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Mcleod’s Pharmaceuticals (India) SWOT Analysis
2.10.4 Mcleod’s Pharmaceuticals (India) Product and Services
2.10.5 Mcleod’s Pharmaceuticals (India) Brain Tumor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.11 Dr. Reddy’s Laboratories (India)
2.11.1 Dr. Reddy’s Laboratories (India) Details
2.11.2 Dr. Reddy’s Laboratories (India) Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Dr. Reddy’s Laboratories (India) SWOT Analysis
2.11.4 Dr. Reddy’s Laboratories (India) Product and Services
2.11.5 Dr. Reddy’s Laboratories (India) Brain Tumor Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Brain Tumor Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Brain Tumor Treatment Players Market Share
3.2.2 Top 10 Brain Tumor Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Brain Tumor Treatment Revenue and Market Share by Regions
4.2 North America Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
5 North America Brain Tumor Treatment Revenue by Countries
5.1 North America Brain Tumor Treatment Revenue by Countries (2015-2020)
5.2 USA Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
6 Europe Brain Tumor Treatment Revenue by Countries
6.1 Europe Brain Tumor Treatment Revenue by Countries (2015-2020)
6.2 Germany Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
6.4 France Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Brain Tumor Treatment Revenue by Countries
7.1 Asia-Pacific Brain Tumor Treatment Revenue by Countries (2015-2020)
7.2 China Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
7.5 India Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
8 South America Brain Tumor Treatment Revenue by Countries
8.1 South America Brain Tumor Treatment Revenue by Countries (2015-2020)
8.2 Brazil Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Brain Tumor Treatment by Countries
9.1 Middle East & Africa Brain Tumor Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Brain Tumor Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Brain Tumor Treatment Market Forecast by Type (2019-2024)
10.3 Surgery Revenue Growth Rate (2015-2025)
10.4 Radiation Therapy Revenue Growth Rate (2015-2025)
10.5 Chemotherapy Revenue Growth Rate (2015-2025)
10.6 Immunotherapy Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Brain Tumor Treatment Market Segment by Application
11.1 Global Brain Tumor Treatment Revenue Market Share by Application (2015-2020)
11.2 Brain Tumor Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals and Clinics Revenue Growth (2015-2020)
11.4 Others Revenue Growth (2015-2020)
12 Global Brain Tumor Treatment Market Size Forecast (2021-2025)
12.1 Global Brain Tumor Treatment Market Size Forecast (2021-2025)
12.2 Global Brain Tumor Treatment Market Forecast by Regions (2021-2025)
12.3 North America Brain Tumor Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Brain Tumor Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Brain Tumor Treatment Revenue Market Forecast (2021-2025)
12.6 South America Brain Tumor Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Brain Tumor Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Brain Tumor Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Brain Tumor Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Brain Tumor Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Brain Tumor Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Genetech (U.S.) Corporate Information, Location and Competitors
Table 6. Genetech (U.S.) Brain Tumor Treatment Major Business
Table 7. Genetech (U.S.) Brain Tumor Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Genetech (U.S.) SWOT Analysis
Table 9. Genetech (U.S.) Brain Tumor Treatment Product and Solutions
Table 10. Genetech (U.S.) Brain Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Merck (U.S.) Corporate Information, Location and Competitors
Table 12. Merck (U.S.) Brain Tumor Treatment Major Business
Table 13. Merck (U.S.) Brain Tumor Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Merck (U.S.) SWOT Analysis
Table 15. Merck (U.S.) Brain Tumor Treatment Product and Solutions
Table 16. Merck (U.S.) Brain Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Astra Zeneca (India) Corporate Information, Location and Competitors
Table 18. Astra Zeneca (India) Brain Tumor Treatment Major Business
Table 19. Astra Zeneca (India) Brain Tumor Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Astra Zeneca (India) SWOT Analysis
Table 21. Astra Zeneca (India) Brain Tumor Treatment Product and Solutions
Table 22. Astra Zeneca (India) Brain Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Bristol Mayers Squibb (U.S.) Corporate Information, Location and Competitors
Table 24. Bristol Mayers Squibb (U.S.) Brain Tumor Treatment Major Business
Table 25. Bristol Mayers Squibb (U.S.) Brain Tumor Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Bristol Mayers Squibb (U.S.) SWOT Analysis
Table 27. Bristol Mayers Squibb (U.S.) Brain Tumor Treatment Product and Solutions
Table 28. Bristol Mayers Squibb (U.S.) Brain Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Antisenese Pharma (Mongolia) Corporate Information, Location and Competitors
Table 30. Antisenese Pharma (Mongolia) Brain Tumor Treatment Major Business
Table 31. Antisenese Pharma (Mongolia) Brain Tumor Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Antisenese Pharma (Mongolia) SWOT Analysis
Table 33. Antisenese Pharma (Mongolia) Brain Tumor Treatment Product and Solutions
Table 34. Antisenese Pharma (Mongolia) Brain Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Hoffman-La Roche (Switzerland) Corporate Information, Location and Competitors
Table 36. Hoffman-La Roche (Switzerland) Brain Tumor Treatment Major Business
Table 37. Hoffman-La Roche (Switzerland) Brain Tumor Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Hoffman-La Roche (Switzerland) SWOT Analysis
Table 39. Hoffman-La Roche (Switzerland) Brain Tumor Treatment Product and Solutions
Table 40. Hoffman-La Roche (Switzerland) Brain Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Mankind Pharma (India) Corporate Information, Location and Competitors
Table 42. Mankind Pharma (India) Brain Tumor Treatment Major Business
Table 43. Mankind Pharma (India) Brain Tumor Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Mankind Pharma (India) SWOT Analysis
Table 45. Mankind Pharma (India) Brain Tumor Treatment Product and Solutions
Table 46. Mankind Pharma (India) Brain Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Novartis (Switzerland) Corporate Information, Location and Competitors
Table 48. Novartis (Switzerland) Brain Tumor Treatment Major Business
Table 49. Novartis (Switzerland) Brain Tumor Treatment Total Revenue (USD Million) (2017-2018)
Table 50. Novartis (Switzerland) SWOT Analysis
Table 51. Novartis (Switzerland) Brain Tumor Treatment Product and Solutions
Table 52. Novartis (Switzerland) Brain Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Pfizer (U.S.) Corporate Information, Location and Competitors
Table 54. Pfizer (U.S.) Brain Tumor Treatment Major Business
Table 55. Pfizer (U.S.) Brain Tumor Treatment Total Revenue (USD Million) (2017-2018)
Table 56. Pfizer (U.S.) SWOT Analysis
Table 57. Pfizer (U.S.) Brain Tumor Treatment Product and Solutions
Table 58. Pfizer (U.S.) Brain Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Mcleod’s Pharmaceuticals (India) Corporate Information, Location and Competitors
Table 60. Mcleod’s Pharmaceuticals (India) Brain Tumor Treatment Major Business
Table 61. Mcleod’s Pharmaceuticals (India) Brain Tumor Treatment Total Revenue (USD Million) (2017-2018)
Table 62. Mcleod’s Pharmaceuticals (India) SWOT Analysis
Table 63. Mcleod’s Pharmaceuticals (India) Brain Tumor Treatment Product and Solutions
Table 64. Mcleod’s Pharmaceuticals (India) Brain Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Dr. Reddy’s Laboratories (India) Corporate Information, Location and Competitors
Table 66. Dr. Reddy’s Laboratories (India) Brain Tumor Treatment Major Business
Table 67. Dr. Reddy’s Laboratories (India) Brain Tumor Treatment Total Revenue (USD Million) (2017-2018)
Table 68. Dr. Reddy’s Laboratories (India) SWOT Analysis
Table 69. Dr. Reddy’s Laboratories (India) Brain Tumor Treatment Product and Solutions
Table 70. Dr. Reddy’s Laboratories (India) Brain Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Global Brain Tumor Treatment Revenue (Million USD) by Players (2015-2020)
Table 72. Global Brain Tumor Treatment Revenue Share by Players (2015-2020)
Table 73. Global Brain Tumor Treatment Revenue (Million USD) by Regions (2015-2020)
Table 74. Global Brain Tumor Treatment Revenue Market Share by Regions (2015-2020)
Table 75. North America Brain Tumor Treatment Revenue by Countries (2015-2020)
Table 76. North America Brain Tumor Treatment Revenue Market Share by Countries (2015-2020)
Table 77. Europe Brain Tumor Treatment Revenue (Million USD) by Countries (2015-2020)
Table 78. Asia-Pacific Brain Tumor Treatment Revenue (Million USD) by Countries (2015-2020)
Table 79. South America Brain Tumor Treatment Revenue by Countries (2015-2020)
Table 80. South America Brain Tumor Treatment Revenue Market Share by Countries (2015-2020)
Table 81. Middle East and Africa Brain Tumor Treatment Revenue (Million USD) by Countries (2015-2020)
Table 82. Middle East and Africa Brain Tumor Treatment Revenue Market Share by Countries (2015-2020)
Table 83. Global Brain Tumor Treatment Revenue (Million USD) by Type (2015-2020)
Table 84. Global Brain Tumor Treatment Revenue Share by Type (2015-2020)
Table 85. Global Brain Tumor Treatment Revenue Forecast by Type (2021-2025)
Table 86. Global Brain Tumor Treatment Revenue by Application (2015-2020)
Table 87. Global Brain Tumor Treatment Revenue Share by Application (2015-2020)
Table 88. Global Brain Tumor Treatment Revenue Forecast by Application (2021-2025)
Table 89. Global Brain Tumor Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Brain Tumor Treatment Picture
Figure 2. Global Brain Tumor Treatment Revenue Market Share by Type in 2019
Figure 3. Surgery Picture
Figure 4. Radiation Therapy Picture
Figure 5. Chemotherapy Picture
Figure 6. Immunotherapy Picture
Figure 7. Others Picture
Figure 8. Brain Tumor Treatment Revenue Market Share by Application in 2019
Figure 9. Hospitals and Clinics Picture
Figure 10. Others Picture
Figure 11. Global Brain Tumor Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Brain Tumor Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Brain Tumor Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Brain Tumor Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Brain Tumor Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Brain Tumor Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Brain Tumor Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Brain Tumor Treatment Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Brain Tumor Treatment Revenue Market Share in 2019
Figure 20. Global Top 10 Players Brain Tumor Treatment Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Brain Tumor Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Brain Tumor Treatment Revenue Market Share by Regions (2015-2020)
Figure 24. Global Brain Tumor Treatment Revenue Market Share by Regions in 2018
Figure 25. North America Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Europe Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
Figure 28. South America Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
Figure 30. North America Brain Tumor Treatment Revenue Market Share by Countries (2015-2020)
Figure 31. North America Brain Tumor Treatment Revenue Market Share by Countries in 2019
Figure 32. USA Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Canada Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Europe Brain Tumor Treatment Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Brain Tumor Treatment Revenue Market Share by Countries in 2019
Figure 37. Germany Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
Figure 38. UK Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
Figure 39. France Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Russia Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Italy Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Brain Tumor Treatment Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Brain Tumor Treatment Revenue Market Share by Countries in 2019
Figure 44. China Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Japan Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Korea Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
Figure 47. India Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
Figure 49. South America Brain Tumor Treatment Revenue Market Share by Countries (2015-2020)
Figure 50. South America Brain Tumor Treatment Revenue Market Share by Countries in 2019
Figure 51. Brazil Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Brain Tumor Treatment Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Brain Tumor Treatment Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
Figure 56. UAE Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
Figure 59. Global Brain Tumor Treatment Revenue Share by Type (2015-2020)
Figure 60. Global Brain Tumor Treatment Revenue Share by Type in 2019
Figure 61. Global Brain Tumor Treatment Market Share Forecast by Type (2021-2025)
Figure 62. Global Surgery Revenue Growth Rate (2015-2020)
Figure 63. Global Radiation Therapy Revenue Growth Rate (2015-2020)
Figure 64. Global Chemotherapy Revenue Growth Rate (2015-2020)
Figure 65. Global Immunotherapy Revenue Growth Rate (2015-2020)
Figure 66. Global Others Revenue Growth Rate (2015-2020)
Figure 67. Global Brain Tumor Treatment Revenue Share by Application (2015-2020)
Figure 68. Global Brain Tumor Treatment Revenue Share by Application in 2019
Figure 69. Global Brain Tumor Treatment Market Share Forecast by Application (2021-2025)
Figure 70. Global Hospitals and Clinics Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Brain Tumor Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Brain Tumor Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Brain Tumor Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Brain Tumor Treatment Revenue Market Forecast (2021-2025)
Figure 76. Europe Brain Tumor Treatment Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Brain Tumor Treatment Revenue Market Forecast (2021-2025)
Figure 78. South America Brain Tumor Treatment Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Brain Tumor Treatment Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
脳腫瘍療法の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Brain Tumor Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.0% in the forecast period of 2020 to 2025 and will expected to reach USD 1552.3 million by 2025, from USD 1060.2 million in 2019. The Brain Tumo…- 交流電場腫瘍治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Alternating Electric Field Tumor Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Al…
- 脳動脈瘤治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Brain Aneurysm Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Brain Aneurysm Treat…
- 性索性腺間質腫瘍治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Sex Cord Gonadal Stromal Tumor Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sex …
- 腫瘍治療フィールド（TTFields）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Tumor Treating Fields (TTFields) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tumor Treati…